Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pengo

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Journal of the American College of Cardiology|January 1, 1994
IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarctionM Condorelli, M Chiariello, A Dagianti, et al.
Thrombosis and Haemostasis|April 11, 2013
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndromeA Bontadi, A Ruffatti, E Falcinelli, et al.
Journal of Thrombosis and Haemostasis : JTH|January 10, 2018
Thrombocytopenia in high-risk patients with antiphospholipid syndromeE Pontara, A Banzato, E Bison, et al.
Thrombosis Research|July 12, 2008
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial functionP Gresele, R Migliacci, M C Vedovati, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2013
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profileV Pengo, A Ruffatti, T Del Ross, et al.
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2018
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulantsS Testa, O Paoletti, C Legnani, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2016
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform studyS Testa, C Legnani, A Tripodi, et al.
International Journal of Laboratory Hematology|January 10, 2018
Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory RegisterM Cini, C Legnani, B Cosmi, et al.
Journal of Thrombosis and Haemostasis : JTH|April 28, 2007
Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samplesV Pengo, A Biasiolo, P Gresele, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Journal of the American College of Cardiology|January 1, 1994
IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarctionM Condorelli, M Chiariello, A Dagianti, et al.
Thrombosis and Haemostasis|April 11, 2013
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndromeA Bontadi, A Ruffatti, E Falcinelli, et al.
Journal of Thrombosis and Haemostasis : JTH|January 10, 2018
Thrombocytopenia in high-risk patients with antiphospholipid syndromeE Pontara, A Banzato, E Bison, et al.
Thrombosis Research|July 12, 2008
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial functionP Gresele, R Migliacci, M C Vedovati, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2013
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profileV Pengo, A Ruffatti, T Del Ross, et al.
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2018
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulantsS Testa, O Paoletti, C Legnani, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2016
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform studyS Testa, C Legnani, A Tripodi, et al.
International Journal of Laboratory Hematology|January 10, 2018
Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory RegisterM Cini, C Legnani, B Cosmi, et al.
Journal of Thrombosis and Haemostasis : JTH|April 28, 2007
Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samplesV Pengo, A Biasiolo, P Gresele, et al.
Pageof 17